drugset / Trial / NCT00919282
Gemcitabine (GFF) in Patients With Pancreatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to examine the efficacy and safety of the drug combination GFF in patients with advanced pancreatic cancer (APC).
Timeline
- Start
- 1997-09
- Primary completion
- 2000-07
- Completion
- 2002-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1 g | — |
| Subject | Leucovorin | Small molecule | 500 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 750 mg/m2 | — |